As reviewed above, TRPV4 can possibly potentiate invasion of breast cancer cells through Ca2+-dependent activation of AKT that leads to changes in actin dynamics and downregulation of junctional E-cadherin [240,241]. This evidence concerns the gene CDH1 and breast carcinoma.